
BMS
company0.0Global Dominance: 0.00%
BMS, or Bristol-Myers Squibb Company, is a global biopharmaceutical company headquartered in New York City, known for its commitment to discovering, developing, and delivering innovative medicines for patients with serious diseases. The company has made significant strides in oncology, immunology, and cardiovascular disease, and is recognized for its collaborations with other firms, such as BioNTech, to advance cutting-edge therapies, including cancer treatments.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
BMS is partnering with BioNTech for cancer drug development.
Alman BioNTech ile ABD'li şirket anlaşma imzaladı... Kanser ilacı geliştireceklerHürriyet·
Turkey· 2025-06-02

